173 related articles for article (PubMed ID: 9513075)
21. In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression.
Rawstron AC; Barrans SL; Blythe D; English A; Richards SJ; Fenton JA; Davies FE; Child JA; Jack AS; Morgan GJ
Br J Haematol; 2001 Jun; 113(3):794-802. PubMed ID: 11380472
[TBL] [Abstract][Full Text] [Related]
22. Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9.
Letarte M; Seehafer JG; Greaves A; Masellis-Smith A; Shaw AR
Leukemia; 1993 Jan; 7(1):93-103. PubMed ID: 7678118
[TBL] [Abstract][Full Text] [Related]
23. Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation.
Petersen AJ; Brown RD; Pope BB; Jamieson GP; Paterson AR; Gibson J; Wiley JS; Joshua DE
Leuk Lymphoma; 1994 May; 13(5-6):491-9. PubMed ID: 8069194
[TBL] [Abstract][Full Text] [Related]
24. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells.
Sakai A; Fujii T; Noda M; Hyodo H; Oda K; Kimura A
Am J Hematol; 1996 Dec; 53(4):251-3. PubMed ID: 8948665
[TBL] [Abstract][Full Text] [Related]
25. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
Makrynikola V; Bianchi A; Bradstock K; Gottlieb D; Hewson J
Leukemia; 1994 Oct; 8(10):1734-43. PubMed ID: 7523799
[TBL] [Abstract][Full Text] [Related]
26. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
27. A hierarchy for integrin expression and adhesiveness among T cell subsets that is linked to TCR gene usage and emphasizes V delta 1+ gamma delta T cell adherence and tissue retention.
Nakajima S; Roswit WT; Look DC; Holtzman MJ
J Immunol; 1995 Aug; 155(3):1117-31. PubMed ID: 7636183
[TBL] [Abstract][Full Text] [Related]
28. High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow.
Chen C; Mobley JL; Dwir O; Shimron F; Grabovsky V; Lobb RR; Shimizu Y; Alon R
J Immunol; 1999 Jan; 162(2):1084-95. PubMed ID: 9916737
[TBL] [Abstract][Full Text] [Related]
29. The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells.
Rawstron AC; Fenton JA; Ashcroft J; English A; Jones RA; Richards SJ; Pratt G; Owen R; Davies FE; Child JA; Jack AS; Morgan G
Blood; 2000 Dec; 96(12):3880-6. PubMed ID: 11090073
[TBL] [Abstract][Full Text] [Related]
30. Adherence of normal and neoplastic human B cell precursors to the bone marrow microenvironment.
Ryan DH
Blood Cells; 1993; 19(2):225-41; discussion 241-4. PubMed ID: 7906154
[TBL] [Abstract][Full Text] [Related]
31. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells.
Ryan DH; Nuccie BL; Abboud CN; Winslow JM
J Clin Invest; 1991 Sep; 88(3):995-1004. PubMed ID: 1715889
[TBL] [Abstract][Full Text] [Related]
32. Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.
Heider U; Langelotz C; Jakob C; Zavrski I; Fleissner C; Eucker J; Possinger K; Hofbauer LC; Sezer O
Clin Cancer Res; 2003 Apr; 9(4):1436-40. PubMed ID: 12684416
[TBL] [Abstract][Full Text] [Related]
33. High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myeloma.
Kawano MM; Mahmoud MS; Huang N; Lisukov IA; Mihara K; Tsujimoto T; Kuramoto A
Br J Haematol; 1995 Dec; 91(4):860-4. PubMed ID: 8547130
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-11 enhancement of VLA-5 mediated adhesion of CD34+ cells from cord blood to fibronectin is associated with the PI-3 kinase pathway.
Wang LS; Liu HJ; Broxmeyer HE; Lu L
In Vivo; 2000; 14(2):331-7. PubMed ID: 10836206
[TBL] [Abstract][Full Text] [Related]
35. Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells.
Yi Q; Dabadghao S; Osterborg A; Bergenbrant S; Holm G
Blood; 1997 Sep; 90(5):1960-7. PubMed ID: 9292530
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: possible involvement of MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells.
Huang N; Kawano MM; Harada H; Harada Y; Sakai A; Kuramoto A; Niwa O
Blood; 1993 Dec; 82(12):3721-9. PubMed ID: 8260709
[TBL] [Abstract][Full Text] [Related]
37. Human skin mast cells express functional beta 1 integrins that mediate adhesion to extracellular matrix proteins.
Columbo M; Bochner BS; Marone G
J Immunol; 1995 Jun; 154(11):6058-64. PubMed ID: 7538541
[TBL] [Abstract][Full Text] [Related]
38. Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma.
Matsuo Y; Drexler HG; Nishizaki C; Harashima A; Fukuda S; Kozuka T; Sezaki T; Orita K
Br J Haematol; 2000 Apr; 109(1):54-63. PubMed ID: 10848782
[TBL] [Abstract][Full Text] [Related]
39. Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma.
Jensen GS; Belch AR; Mant MJ; Ruether BA; Yacyshyn BR; Pilarski LM
Am J Hematol; 1993 May; 43(1):29-36. PubMed ID: 7686332
[TBL] [Abstract][Full Text] [Related]
40. The incidence of DNA aneuploidy in multiple myeloma does not correlate with stage of disease.
Nowak R; Oelschlägel U; Range U; Mölle M; Ehninger G
Am J Clin Pathol; 1998 Feb; 109(2):226-32. PubMed ID: 9583896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
